Hence, most clinical interpretations highlight the relevance of ERK1/2 signaling to breast cancer; however, conflicting results have been reported [19, 20] and highlight the fact that the contradictory nature of ERK signaling in breast cancer remains unexplained. This evidence concerns the gene MAPK3 and breast carcinoma.